Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease? Marc EvansSylvie DejagerJames E. Foley Commentary Open access 18 March 2015 Pages: 1 - 5
A Systematic Review of the Direct Economic Burden of Type 2 Diabetes in China Huimei HuMonika SawhneyHengjin Dong Review Open access 05 February 2015 Pages: 7 - 16
Efficacy and Safety of a Single-Pill Combination of Vildagliptin and Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Trial Masato OdawaraMika YoshikiWolfgang Kothny Original Research Open access 18 February 2015 Pages: 17 - 27
Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials Elizabeth S. OmmenLei XuSamuel S. Engel Original Research Open access 30 January 2015 Pages: 29 - 40
Liraglutide as Add-On Therapy to Insulin in Type 2 Diabetes Mellitus: A Retrospective, Observational Study From a Daily Clinical Practice Setting in Switzerland Christof LipowskyLisa SzeMichael Brändle Original Research Open access 10 January 2015 Pages: 41 - 47
Starting Insulin in Type 2 Diabetes: Real-World Outcomes After the First 12 Months of Insulin Therapy in a New Zealand Cohort Shekhar SehgalManish Khanolkar Original Research Open access 14 February 2015 Pages: 49 - 60
Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin Antonio PérezPedro Mezquita RayaWilliam J. Valentine Original Research Open access 06 March 2015 Pages: 61 - 74
A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes Mellitus A. Brett HauberKaan TunceliLarry Radican Original Research Open access 14 January 2015 Pages: 75 - 84
Dialing Torque Preferences of People with Diabetes When Using Insulin Pens: A Pilot Study Arnd FriedrichsMario SchmitzSteffen Adler Original Research Open access 27 January 2015 Pages: 85 - 93
Erratum to: Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology Sanjay Kalra Erratum Open access 15 January 2015 Pages: 95 - 95
Erratum to: Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials Elizabeth S. OmmenLei XuSamuel S. Engel Erratum Open access 24 February 2015 Pages: 97 - 98
Erratum to: Starting Insulin in Type 2 Diabetes: Real-World Outcomes After the First 12 Months of Insulin Therapy in a New Zealand Cohort Shekhar SehgalManish Khanolkar Erratum Open access 27 February 2015 Pages: 99 - 99